<html>
<head>PUBMED IDs for KSP37</head>
<body bgcolor='#C5F0F2'><h1>KSP37</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16652150/'>Identification of expressed genes characterizing long-term survival in malignant glioma patients.</a> May 3  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/21079801/'>POLD2 and KSP37 (FGFBP2) correlate strongly with histology, stage and outcome in ovarian carcinomas.</a> April 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/27032399/'>Killer-specific secretory (Ksp37) gene expression in subjects with Down's syndrome.</a> January 14  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27032393/'>SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer.</a> April 2  2016<br></body></html>
